The Effects of Delay in Treatment on Survival Rates in Carcinoma of the Breast

Sheridan, Brian; Fleming, Justin; Atkinson, Leicester; Scott, Godfrey

doi:10.5694/j.1326-5377.1971.tb87551.x

Cited by 22 publications

(4 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The literature regarding the effects of treatment delay and duration of symptoms on survival in patients with breast carcinoma contains conflicting findings,28–40 but the metaanalysis performed by Richards et al41 concluded that a delay of 3–6 months from symptom recognition to the start of treatment was associated with a lower survival rate than was a delay of < 3 months and that a delay of > 6 months was associated with a lower survival rate than was a delay of < 6 months. The majority of women in the current study began treatment within 3 months of their initial consultation; however, approximately 22% of African American women and 14% of white women had delays of ≥ 3 months between consultation and treatment, a finding that raises the possibility that delays in the provision of medical care may have been clinically significant.…”

Section: Discussionmentioning

confidence: 99%

“…Delays in the diagnosis of breast carcinoma or in the initiation of breast carcinoma treatment may affect disease stage at presentation and influence survival, but there is disagreement regarding whether breast carcinoma survival and disease recurrence are related to the duration of symptoms or to the length of the delay in treatment initiation 28–40. A metaanalysis performed by Richards et al41 indicated that a delay of 3–6 months between the appearance of symptoms and the initiation of treatment was associated with a lower survival rate than was a delay of < 3 months and that a delay of > 6 months was associated with a lower survival rate than was a delay of < 6 months.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Racial differences in diagnosis, treatment, and clinical delays in a population‐based study of patients with newly diagnosed breast carcinoma

Gwyn

Bondy

Cohen

et al. 2004

Cancer

183

137

View full text Add to dashboard Cite

BACKGROUND Few studies have addressed the issue of whether delays in the interval between medical consultation and the diagnosis and treatment of breast carcinoma are greater for African American women than for white women. The authors examined differences with respect to these delays and analyzed the factors that may have contributed to such differences among women ages 20–54 years who had invasive breast carcinoma diagnosed between 1990 and 1992 and who lived in Atlanta, Georgia. METHODS A total of 251 African American women and 580 white women were interviewed and had their medical records reviewed. The authors estimated racial differences in delay times and used polytomous logistic regression to determine the contributions of various factors (socioeconomic and other) to these differences. RESULTS Although most women in both groups were treated within 3 months of initial consultation, 22.4% of African American women and 14.3% of white women had clinical delays of > 3 months. Compared with white women, African American women were more likely to experience delays in diagnosis and treatment. Access to care (as represented by method of detection and insurance status) and poverty index partially accounted for these differences in delay time; however, racial differences in terms of delayed treatment and diagnosis remained even after adjustment for contributing factors. CONCLUSIONS The findings of the current study suggest that among women ages 20–54 years who have breast carcinoma, potentially clinically significant differences in terms of delayed diagnosis and treatment exist between African American women and white women. Improvements in access to care and in socioeconomic circumstances may address these differences to some degree, but additional research is needed to identify other contributing factors. Cancer 2004. Published 2004 American Cancer Society.

show abstract

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Racial differences in diagnosis, treatment, and clinical delays in a population‐based study of patients with newly diagnosed breast carcinoma

Gwyn

Bondy

Cohen

et al. 2004

Cancer

183

137

View full text Add to dashboard Cite

show abstract

“…1999). Poor cancer survival can be attributed to many factors, including delay in access to appropriate care (Sheridan et al . 1971; Wilkinson et al .…”

Section: Introductionmentioning

confidence: 99%

The journey towards a cancer diagnosis: the experiences of people with cancer, their family and carers

Leydon

Bynoe-Sutherland

Coleman

2003

European Journal of Cancer Care

View full text Add to dashboard Cite

This small-scale study aimed to provide an insight into the time between first noticing a symptom, attending a healthcare provider and obtaining a cancer diagnosis. Previous research showed that the pre-diagnostic moments on the illness trajectory were important to people with cancer and could influence levels of satisfaction with subsequent care. This article provides an overview of the qualitative component (phase 2) of a three-pronged study that involved a workshop, a literature review and focus groups and interviews with people affected by cancer. Results highlighted some of the difficulties encountered during the complex journey towards a diagnosis of cancer. These included fear of what might be found, communication of symptoms to healthcare practitioners, the influence of family on decisions to attend a primary care practitioner and the importance of a person's gender on perceptions of health-seeking behaviour. Results presented warrant further investigation and suggest the importance of viewing the 'cancer journey' as including the journey leading up to a diagnosis of cancer.

show abstract

“…We identified and examined eightyseven studies (101,954 patients) that included direct data relating delay (including patient delay) and survival that were published between 1907 and 1996. For analytical purposes, each study was categorized into one of three groups: category I, where groups with delays of less than three months, less than six months, or both had actual survival rates available five years after diagnosis; category II, where the investigators reported additional analyses but did not report actual survival rates at five years [36]. 4) Other Factors Related to Dalay: Aside from survival, a number of other variables, such as disease stage, tumor size, and lymph node involvement upon diagnosis, have also been linked to treatment delays.…”

Section: Effect For Waiting For Treatment 1)mentioning

confidence: 99%

Review Article on Breast Cancer

Sonavane,

Shinde,

Raut

2024

IJRASET

View full text Add to dashboard Cite

However being rare in women, breast cancer can have a substantial morbidity and fatality rate. The goal of the current review is to ascertain whether breast cancer treatment and evaluation methods used on female patients are suitable for this type of cancer. In comparison to male breast cancer, female breast cancer differs biologically in that it is more common in some regions of Africa, has a higher frequency of oestrogen receptor positive, and has more aggressive clinical behavior. It reacts to chemotherapy and hormonal therapy, yet it is unknown what the best treatment plans are for female patients. Breast cancer in women is still a rare condition. The majority of what we currently know about its biology, natural history, and methods of therapy has been derived from research on its female counterpart.

show abstract

The Effects of Delay in Treatment on Survival Rates in Carcinoma of the Breast

Cited by 22 publications

References 6 publications

Racial differences in diagnosis, treatment, and clinical delays in a population‐based study of patients with newly diagnosed breast carcinoma

Racial differences in diagnosis, treatment, and clinical delays in a population‐based study of patients with newly diagnosed breast carcinoma

The journey towards a cancer diagnosis: the experiences of people with cancer, their family and carers

Review Article on Breast Cancer

Contact Info

Product

Resources

About